Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Curcumin applied to the skin can start hair growth in mice.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Inhibiting ODC can prevent UV-induced skin cancer.

p63 is essential for skin cell growth and differentiation by controlling specific gene networks.

Six existing drugs may help block virus entry in COVID-19.

New cancer drugs often cause skin and nail problems.

Vitamin D receptor helps prevent skin tumors.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

New treatments targeting specific genes show promise for treating keratin disorders.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

EGFR inhibitors for lung cancer can cause severe skin issues.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.